1-5 of 5
pharmacotherapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis

Clinical Trials & Observations
Naveen Pemmaraju, Bing Z. Carter, Prithviraj Bose, Nitin Jain, Tapan M. Kadia, Guillermo Garcia-Manero, Carlos E. Bueso-Ramos, Courtney D. DiNardo, Sharon Bledsoe, Naval G. Daver, Uday Popat, Marina Y. Konopleva, Lingsha Zhou, Sherry Pierce, Zeev E. Estrov, Gautam M. Borthakur, Maro Ohanian, Wei Qiao, Lucia Masarova, Xuemei Wang, Po Yee Mak, Jorge Cortes, Elias Jabbour, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3163–3173.
https://doi.org/10.1182/bloodadvances.2020003829
Published: 2021
Journal Articles

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain

Amanda M. Brandow, C. Patrick Carroll, Susan Creary, Ronisha Edwards-Elliott, Jeffrey Glassberg, Robert W. Hurley, Abdullah Kutlar, Mohamed Seisa, Jennifer Stinson, John J. Strouse, Fouza Yusuf, William Zempsky, Eddy Lang
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2656–2701.
https://doi.org/10.1182/bloodadvances.2020001851
Published: 2020
Includes: Supplemental data
Journal Articles

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Clinical Trials & Observations
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell Y. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2057–2068.
https://doi.org/10.1182/bloodadvances.2019000201
Published: 2019
Includes: Supplemental data
Journal Articles

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

Clinical Trials & Observations
Leylah M. Drusbosky, Neeraj Kumar Singh, Kimberly E. Hawkins, Cesia Salan, Madeleine Turcotte, Elizabeth A. Wise, Amy Meacham, Vindhya Vijay, Glenda G. Anderson, Charlie C. Kim, Saumya Radhakrishnan, Yashaswini Ullal, Anay Talawdekar, Huzaifa Sikora, Prashant Nair, Arati Khanna-Gupta, Taher Abbasi, Shireen Vali, Subharup Guha, Nosha Farhadfar, Hemant S. Murthy, Biljana N. Horn, Helen L. Leather, Paul Castillo, Caitlin Tucker, Christina Cline, Leslie Pettiford, Jatinder K. Lamba, Jan S. Moreb, Randy A. Brown, Maxim Norkin, John W. Hiemenz, Jack W. Hsu, William B. Slayton, John R. Wingard, Christopher R. Cogle
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1837–1847.
https://doi.org/10.1182/bloodadvances.2018028316
Published: 2019
Includes: Supplemental data
Journal Articles

The role of targeted therapy in the management of patients with AML

Clinical Trials & Observations
Alexander E. Perl
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2281–2294.
https://doi.org/10.1182/bloodadvances.2017009829
Published: 2017